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A20 critically controls microglia activation
and inhibits inﬂammasome-dependent
neuroinﬂammation
Soﬁe Voet1,2, Conor Mc Guire1,2,3,4, Nora Hagemeyer5, Arne Martens1,2, Anna Schroeder6,7, Peter Wieghofer5,14,
Carmen Daems8, Ori Staszewski5, Lieselotte Vande Walle1,9, Marta Joana Costa Jordao 5, Mozes Sze1,2,
Hanna-Kaisa Vikkula1,2, Delphine Demeestere1,2, Griet Van Imschoot1,2, Charlotte L. Scott1,2, Esther Hoste 1,2,
Amanda Gonçalves1,2,10, Martin Guilliams 1,2, Saskia Lippens1,2,10, Claude Libert1,2,
Roos E. Vandenbroucke 1,2, Ki-Wook Kim11,15, Steffen Jung 11, Zsuzsanna Callaerts-Vegh12, Patrick Callaerts8,
Joris de Wit6,7, Mohamed Lamkanﬁ 1,9, Marco Prinz5,13 & Geert van Loo1,2
Microglia, the mononuclear phagocytes of the central nervous system (CNS), are important
for the maintenance of CNS homeostasis, but also critically contribute to CNS pathology.
Here we demonstrate that the nuclear factor kappa B (NF-κB) regulatory protein A20 is
crucial in regulating microglia activation during CNS homeostasis and pathology. In mice,
deletion of A20 in microglia increases microglial cell number and affects microglial regulation
of neuronal synaptic function. Administration of a sublethal dose of lipopolysaccharide
induces massive microglia activation, neuroinﬂammation, and lethality in mice with microglia-
conﬁned A20 deﬁciency. Microglia A20 deﬁciency also exacerbates multiple sclerosis (MS)-
like disease, due to hyperactivation of the Nlrp3 inﬂammasome leading to enhanced inter-
leukin-1β secretion and CNS inﬂammation. Finally, we conﬁrm a Nlrp3 inﬂammasome sig-
nature and IL-1β expression in brain and cerebrospinal ﬂuid from MS patients. Collectively,
these data reveal a critical role for A20 in the control of microglia activation and
neuroinﬂammation.
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The central nervous system (CNS) is considered animmune-privileged site where local immune defense issecured by a group of CNS-resident myeloid cells,
including parenchymal microglia, macrophages at CNS inter-
faces, and a small number of dendritic cells. Microglia are dis-
tributed throughout the brain and spinal cord and are constantly
surveilling the CNS to detect signs of pathogenic invasion or
tissue damage. Upon activation, they orchestrate an innate
immune response and are involved in clearing debris to restore
CNS homeostasis1. Besides their role as immune sentinels,
microglia also support and monitor synaptic function, control
synaptogenesis and are vital for the survival of neurons during
development1,2. However, it is increasingly recognized that under
pathological conditions microglia can acquire a detrimental pro-
inﬂammatory phenotype that actively contributes to the chroni-
city of inﬂammatory brain diseases1. These activated microglia
not only secrete inﬂammatory cytokines and chemokines and
present antigens to immune cells inducing CNS inﬂammation1,3,
they can also induce highly reactive A1 astrocytes that secrete a
soluble toxin that directly kills neurons and oligodendrocytes4.
Although, ontogenetically distinct, microglia share many sur-
face markers with blood-derived monocytes, precluding their
discrimination from inﬁltrating inﬂammatory monocytes and the
study of their speciﬁc roles in inﬂammatory responses. Recently, a
microglia targeting strategy in mice exploiting the CX3 chemo-
kine receptor 1 (CX3CR1) promoter has been developed allowing
the efﬁcient deletion of a speciﬁc gene in microglia and other
CNS macrophages5–7. Here we took advantage of this selective
targeting strategy to address the role of microglia-expressed A20
in CNS homeostasis and pathology. Although, defects in A20-
dependent regulation of nuclear factor kappa B (NF-κB)-depen-
dent gene expression contributes to a variety of inﬂammatory and
autoimmune diseases8, its role in microglia activation is largely
unexplored. Using conditional microglia A20 knockout mice, we
here characterized the function of A20 in microglia under both
physiological and pathological conditions.
Results
Characterization of mice with A20 deﬁciency in microglia.
Transcriptome analysis of puriﬁed brain cell types of mouse
cortex identiﬁes the A20 encoding gene Tnfaip3/A20 as highly
expressed in microglia, in contrast to its expression in neurons,
astrocytes, endothelial cells, pericytes, and oligodendrocytes in
various maturation stages9. To investigate the importance of A20
for microglia development and function, we ﬁrst examined the
expression of A20 in different microglial developmental stages,
including yolk sac precursors (EMPs, A1, A2), embryonic
microglia and adult microglia (Fig. 1a). Although, A20 is only
marginally expressed in early development, an increase in
expression is seen in the later stages of embryonic development,
and A20 expression is further enhanced in adult microglia. To
assess its function in vivo, we crossed mice carrying a ﬂoxed A20
allele (A20FL)10 to Cx3Cr1CreErt2 transgenic mice allowing Cre-
mediated gene deletion following tamoxifen (TAM) treatment
(Supplementary Fig. 1a). Targeting of microglia using this system
is based on microglia longevity and capacity of self-renewal
without any appreciable input from circulating blood cells5,11,12.
A20FLCx3Cr1CreErt2 mice were injected with TAM inducing A20
deletion in all Cx3Cr1-expressing cells. However, due to their
short half-life, Cx3Cr1 Ert2Cre+ expressing blood-derived
monocytes are gradually replaced by their monocyte precursors
harboring non-rearranged A20 alleles (Supplementary Fig. 1b).
A20 deletion in microglia was conﬁrmed at the protein level by
western blotting of ﬂuorescence-activated cell sorted (FACS)
microglia ex vivo (Fig. 1b) and of primary microglia cultured
in vitro (Fig. 1c). In contrast, no deletion could be observed in
bone marrow-derived macrophages (BMDM) and peritoneal
macrophages in vitro or FACS-sorted Kupffer cells, showing A20
expression 4 weeks after TAM treatment (Supplementary
Fig. 1c–e). In addition, we took advantage of the previously
reported Cx3cr1Ert2CreER: Rosa26-ﬂ-STOP-ﬂ-YFP reporter
mouse line5,13 to analyze the level of Cre-mediated recombination
events in Cx3Cr1-expressing macrophages that reside in other
organs. In line with our other observations, we observed low to
negligible YFP expression in heart, lung, liver, and skin macro-
phages, whereas 80–90% of microglia contained high YFP levels
that remained relatively stable over time (Supplementary Fig. 1f).
Together, these results demonstrate that A20FLCx3Cr1CreErt2 mice
efﬁciently and selectively delete A20 expression in microglia.
Mice with TAM-induced A20 deﬁciency in microglia
(A20FL/FLCx3Cr1CreErt2, hereafter named A20Cx3Cr1-KO) do not
display overt spontaneous abnormalities, and histological analysis of
brain sections of A20Cx3Cr1-KO mice do not reveal any gross
morphological defects, astrogliosis or demyelination (Supplemen-
tary Fig. 2). However, immunohistochemical examination with the
microglia marker Iba-1+ revealed a signiﬁcant increase in the
number of microglia both in brain (p= 0.0286) and spinal cord
sections of A20Cx3Cr1-KO mice compared with control littermates
(Fig. 1d–f, Supplementary Fig. 3a). The enhanced presence of
microglia in A20Cx3Cr1-KO CNS was conﬁrmed by manual counting
of Iba-1+ microglia and by FACS analysis of CD45intCD11b+ cells
from brain, implicating increased microglial proliferation as
demonstrated by Ki67 immunostaining one week post TAM
injection (Supplementary Fig. 3b). Quantitative morphometric
three-dimensional (3D) analysis of Iba-1+ microglia in the adult
cortex showed that A20-deﬁcient microglia have an altered
morphology, characterized by signiﬁcantly longer processes and
increased number of segments, branching, and terminal points
relative to microglia from control mice (Fig. 1g, h and
Supplementary Fig. 4). Together, these data suggest that lack of
A20 induces proliferation of adult microglia with altered
morphology.
Next, to determine whether A20 deﬁciency in microglia affects
microglia activation or its immune function under homeostatic
conditions, we expression proﬁled sorted CD45intCD11b+ micro-
glia from brains of A20Cx3Cr1-KO and control littermate mice by
quantitative deep sequencing of RNA transcripts. We observed
signiﬁcant differences in the mRNA proﬁles of microglial genes in
A20Cx3Cr1-KO relative to control mice. In total, 216 genes were
signiﬁcantly upregulated and 39 genes were downregulated (p <
0.01 and fourfold change) in A20Cx3Cr1-KO microglia compared
with controls (Supplementary Fig. 5a and Supplementary Data 1).
Many genes typically expressed under physiological conditions
(P2ry12, Cx3cr1, Sall1, Gpr34, Fcrls, Rhob, Olfml3) are selectively
downregulated Bijschrijven dat het signiﬁcant verschillend is? in
A20Cx3Cr1-KO microglia (Fig. 1i and Supplementary Fig. 5b).
Among all upregulated transcripts in A20Cx3Cr1-KO microglia, we
identiﬁed genes linked to cell activation (Cd45, F4/80, Cd86, Cd40,
Cd11c), microglia polarization (Cxcl10, C4a/C4b, Tnfsf10, Cxcl9,
Ccl2, Ccl5, Tlr1, Il1b), MHC class I (H2k1, H2d1, B2m, H2q7,
H2m3, H2q8), type I interferon signaling (Irf-1, Irf-7, Irf-9, Stat1,
Stat2, Iﬁ35, Iﬁt1, Iﬁt3, IﬁtM3), and inﬂammatory signaling (Nfkb1,
Nfkb2, Relb, Il1b, Il12b, Ccl2, Ccl5, Ccl12, Cxcl9, Cxcl10, Cxcl11,
Cxcl13) (Fig. 1j and Supplementary Fig. 5c). Next, we analyzed the
expression of “disease-associated microglia” (DAM) markers that
have recently been identiﬁed14, and demonstrate the signiﬁcant
upregulation of many of these DAM genes (Axl, Cst7, Ctsl, Cd9,
Csf1, Itgax, Clec7a, Lilrb4, Timp2, Ctsd, Ctsb) in A20Cx3Cr1-KO
microglia (Supplementary Fig. 5d). Also the gene encoding for
apolipoprotein E (Apoe), which has also been linked to a microglia
disease-associated phenotype15, is signiﬁcantly upregulated in
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A20Cx3Cr1-KO microglia (Supplementary Fig. 5e). The biological
roles of the genes that were differentially expressed between
A20Cx3Cr1-KO and control microglia were examined using
ingenuity pathway analysis (IPA). Network analysis on differen-
tially expressed genes identiﬁed “antimicrobial response, inﬂam-
matory response, and cell signaling” as the most differential
between both populations, and IPA canonical pathway analysis
identiﬁed pathways associated with interferon signaling, pattern
recognition receptor signaling, complement system, and inﬂam-
matory signaling as being enriched in A20Cx3Cr1-KO microglia
(Supplementary Fig. 5f, g and Supplementary Table 1). Overall, the
gene expression analysis suggests that upon A20 deletion microglia
decrease their homeostatic “surveilling” state expression proﬁle,
and acquire an inﬂammatory, disease-associated signature. Finally,
in agreement with our recent ﬁndings that other CNS macro-
phages, viz. the non-parenchymal macrophages in the subdural
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meningeal, perivascular spaces and choroid plexus, have the same
origin and dynamics as microglia7, we also identiﬁed, through
RNA-seq analyses, signiﬁcant differences in the mRNA proﬁles of
A20-deﬁcient CD45hiCD11b+CD206+ macrophages relative to
control CD45hiCD11b+CD206+ macrophages. However, only 20
genes were signiﬁcantly upregulated and 24 genes were down-
regulated (p < 0.01 and fourfold change) in A20Cx3Cr1-KO
CD45hiCD11b+CD206+ macrophages compared with controls
(Supplementary Fig. 6a and Supplementary Table 2). Also
inﬂammatory genes are upregulated in these A20-deﬁcient
CD45hiCD11b+CD206+ macrophages, although less pronounced
as is the case for A20 deletion in microglia (Supplementary
Fig. 6b). In conclusion, morphometric 3D analysis and genome
signature comparison between microglia from A20Cx3Cr1-KO and
control animals suggest a crucial role for A20 in the control of
microglia activation under steady-state conditions, and demon-
strate that in the absence of A20 microglia adopt a dysfunctional
phenotype.
A20 deﬁciency in microglia affects synaptic function. Previous
studies indicated that alterations in microglial number or acti-
vation can result in functional and structural deﬁcits in cortical
circuits16,17. To evaluate the functional consequences of increased
microglial number and/or activation status for neuronal function,
we prepared acute slices from P30–35 control and A20Cx3Cr1-KO
mice, and analyzed spontaneous glutamatergic synaptic trans-
mission in layer V pyramidal neurons in S1 cortex. No changes in
AP spiking proﬁles or intrinsic membrane properties were found
between pyramidal neurons from control and A20Cx3Cr1-KO mice
(Fig. 2a, Supplementary Fig. 7, Table 1), indicating that cell-
autonomous parameters are likely unaffected in A20Cx3Cr1-KO
mice. However, we observed a marked increase in spontaneous
excitatory postsynaptic current (sEPSC) frequency in A20Cx3Cr1-
KO S1 layer V pyramidal neurons compared with those from
control mice (Fig. 2b–e). The robust increase in sEPCS frequency
in A20Cx3Cr1-KO mice with increased microglial number and
(hyper)activation is consistent with previous studies showing an
increased frequency of spontaneous synaptic transmission fol-
lowing microglia activation18 and a decreased frequency follow-
ing microglia depletion16,17. A small, but signiﬁcant decrease in
sEPSC amplitude was also observed (Fig. 2b, f, g), indicating that
microglia activation could negatively inﬂuence the density of
postsynaptic glutamate receptors on dendrites.
Next, to evaluate whether the observed aberrant excitatory
synaptic function affects learning and memory, A20Cx3Cr1-KO
and control littermate mice were examined in the hidden
platform protocol of the Morris water maze (MWM)19, a very
reliable and robust protocol to investigate hippocampus-
dependent spatial learning and memory20. Over ten training
days, 6 month old female control and A20Cx3Cr1-KO mice showed
similar learning curves to locate the hidden platform using distal
visual cues. Interspersed probe trials on days 6 and 11 showed no
difference in spatial reference memory and a robust preference
for the correct target quadrant. Cognitive ﬂexibility, a measure for
executive function, was assessed in a consecutive 5 day reversal
training where the platform position was relocated to the opposite
quadrant. A20Cx3Cr1-KO and control mice showed similar
learning curves (repeated measures two-way ANOVA for factor
day: F(4,76)= 16.8; p < 0.0001) (Fig. 2h). Interestingly, during the
reversal probe trial only control mice showed a signiﬁcant
preference for the target quadrant over the other three quadrants
(repeated measures two-way ANOVA for factor quadrant
preference: F(3,57)= 11,4; p < 0.0001) (Fig. 2i) and were at any
given time point signiﬁcantly closer to the location of the reversal
platform than to the location of the acquisition platform
(expressed as total distance to target) (two-way ANOVA for
factor platform location: F(1,38)= 14,36; p= 0.0005) (Fig. 2j).
Together these ﬁndings indicate that after 5 days of reversal
learning, A20Cx3Cr1-KO mice do not have a robust spatial
representation of the platform’s correct location and were not
capable of forming a robust reference memory. Together, these
results show that the aberrantly activated microglia in A20Cx3Cr1-
KO mice affect excitatory synaptic function with consequences for
proper cognitive function.
A20 in microglia protects against lipopolysaccharide (LPS)-
induced inﬂammation. Microglia are the CNS-resident immune
cells acting as the ﬁrst responders to microbial infections of the
brain21. To investigate the importance of A20 for microglia
function in a model of neuroinﬂammation, A20Cx3Cr1-KO and
control littermate mice were injected with a single sublethal dose
of the TLR4 agonist LPS, known to induce neuroinﬂammation
through microglia activation and expression of pro-inﬂammatory
cytokines22,23. Surprisingly, in contrast to control mice, which
only exhibit a modest drop in body temperature in the ﬁrst hours
after systemic LPS injection, A20Cx3Cr1-KO mice displayed severe
hypothermia (Fig. 3a) and increased mortality (Fig. 3b). Similarly,
A20Cx3Cr1-KO mice presented severe hypothermia when LPS
was administered by intracerebroventricular (icv) injection
(Supplementary Fig. 8a). Histological analysis of the CNS 10 h
after systemic LPS administration, a time point at which all
A20Cx3Cr1-KO mice are still alive, demonstrated increased
Fig. 1 CNS phenotype of A20Cx3Cr1-KO mice. a A20 expression during microglial cell development. Cells were sorted according to Kierdorf et al.52. A1
immature CD45+ c-kitlo Cx3Cr1− cells (yolk sac), A2 mature CD45+ c-kit− Cx3Cr1+ cells (yolk sac), AM: adult microglia, EM: embryonic microglia (E14),
EMP: erythromyeloid precursors (yolk sac). Each symbol represents one mouse, n= 3 per group. Data presented as mean ± SEM. Signiﬁcant differences
determined by a one-way ANOVA with Tukey correction for multiple comparison (****p < 0.0001). b Immunoblot for A20 expression on ex vivo FACS-
sorted microglia from control (A20FL) and A20Cx3Cr1-KO mice 4 (left) or 35 weeks (right) after TAM injection. Actin is shown as loading control.
c Immunoblot for A20 expression on lysates from primary microglia from control (A20FL) and A20Cx3Cr1-KO mice after stimulation with 4-OH-TAM. Actin
is shown as loading control. Data are representative of two independent experiments. d Immunohistochemistry for Iba-1+ in the cerebral cortex,
hippocampus, and spinal cord of control (A20FL) and A20Cx3Cr1-KO mice. Scale bars: 100 µm (cortex and hippocampus) and 200 µm (spinal cord), insert:
10 and 20 µm, respectively. Representative images are displayed. e Flow cytometric quantiﬁcation of the number of CD45int CD11b+ microglia in brain of
control (A20FL) and A20Cx3Cr1-KO mice 4 weeks post TAM injection. Each symbol represents one mouse. Data are representative of two independent
experiments and presented as mean ± SEM. Signiﬁcant differences determined by Mann–Whitney U-statistical test (*p < 0.05). f Number of Iba-1+
ramiﬁed parenchymal microglia. Each symbol represents one mouse, with four mice per group. Data presented as mean ± SEM. Signiﬁcant differences
determined by a Mann–Whitney U-statistical test (*p < 0.05). g, h 3D reconstruction (scale bars: 10 µm) (g) and Imaris-based quantiﬁcation of cell
morphology (h) of cortical Iba-1+ microglia. Each symbol represents one mouse; three cells analyzed per mouse; n= 5 per condition. Data presented as
mean ± SEM. Signiﬁcant differences determined by a Mann–Whitney U-statistical test (**p < 0.01). i, j RNA sequencing on FACS-sorted microglia from
TAM-injected control (A20FL) and A20Cx3Cr1-KO mice. Each column represents microglia from one individual mouse, n= 5 per group. Color code presents
linear scale. Pathway analysis of RNA-seq datasets demonstrates downregulation of homeostatic genes (i) and upregulation of genes involved in microglia
activation, polarization, MHC class I, interferon and inﬂammatory signaling (j) in A20Cx3Cr1-KO microglia
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microgliosis in A20Cx3Cr1-KO brain and spinal cord compared to
control tissue (Fig. 3c). Since A20 knockout mice with
A20-deﬁcient microglia already spontaneously display a
pro-inﬂammatory phenotype characterized by microglia
hyperproliferation (Fig. 1), no further effect on microglia pro-
liferation is seen after LPS (Fig. 3d). Microglia morphology
analysis 10 h post LPS suggests a reactive phenotype in
A20Cx3Cr1-KO mice compared with wild-type littermates, as
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Fig. 2 Effect of microglia hyperactivation on basal network activity in somatosensory pyramidal neurons. a Example action potential (AP) ﬁring proﬁles,
showing the typical regular spiking behavior of layer V S1 pyramidal neurons both in control and in A20Cx3Cr1-KO neurons. Responses to hyperpolarizing
(−150 pA) and suprathreshold (400 pA) current injections are shown. b Example sEPSC traces, 2s stretches. c Examples of individual sEPSC events.
Individual events shown in gray, averaged event shown as overlay (control, black; A20Cx3Cr1-KO, red). d Cumulative probability distributions of inter-event
sEPSC intervals (IEIs) for control (black) or A20Cx3Cr1-KO (red) cells. e sEPSC frequency (control (black) 5.76 ± 0.58 Hz, n/m= 21/3; A20Cx3Cr1-KO (red)
14.8 ± 1.29 Hz, n/m= 20/3; ****p < 0.0001). Data represents means ± SEM. Number of cells (n), number of animals (m). Statistical differences were
determined by a two-tailed Wilcoxon matched-paired t-test. f Cumulative probability distributions for sEPSC amplitudes in control (black) or A20Cx3Cr1-KO
(red) cells. g sEPSC amplitudes (control 19.3 ± 0.69 pA, n/m= 21/3; A20Cx3Cr1-KO 16.5 ± 0.87 pA, n/m= 20/3; **p= 0.0013). Data represents means ±
SEM. Number cells (n), number of animals (m). Statistical differences were determined by a two-tailed unpaired Mann–Whitney t-test. h Cognitive
ﬂexibility in Morris water maze reversal learning was similar in control (A20FL, n= 12) and A20Cx3Cr1-KO mice (n= 9). i In the reversal probe trial, controls
displayed signiﬁcant target quadrant preference, while A20Cx3Cr1-KO mice did not (T: target quadrant, O: opposite quadrant, A1: adjacent 1 quadrant,
A2: adjacent 2 quadrant). Chance level at 25% is indicated. j During the reversal probe trial, control animals searched closer to the correct reversal location
for the platform than to the old location (distance to platform), while A20Cx3Cr1-KO mice searched at equidistance to both locations. All data (h–j) are
represented as means ± SEM and statistical differences were determined by repeated measures two-way ANOVA (h, i) and two-way ANOVA (j) using
Bonferroni correction for post hoc analysis (h–j) (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)
Table 1 Intrinsic properties of pyramidal neurons from control (A20FL) and A20Cx3Cr1-KO mice (NS, not signiﬁcant)
A20FL (mean ± SEM) A20Cx3Cr1-KO (mean ± SEM) p-value
Passive properties
Input resistance, MΩ 58.8 ± 4.198 60.7 ± 4.783 0.435 (NS)
Resting membrane potential, mV −58.8 ± 1.393 −59.8 ± 1.756 0.670 (NS)
Membrane capacitance, pF 25.3 ± 0.649 26.45 ± 0.813 0.465 (NS)
Membrane time constant, ms 9.2 ± 0.673 9.6 ± 0.651 0.461 (NS)
Action potential (AP) features
First spike latency, ms 87.5 ± 11.999 67.2 ± 11.873 0.310 (NS)
Interspike frequency, Hz 16.4 ± 3.566 18.6 ± 3.786 0.360 (NS)
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evidenced by a signiﬁcantly higher number of processes,
branching points, terminal point, and segments. (Fig. 3e, f and
Supplementary Fig. 4). In agreement, signiﬁcantly elevated levels
of inﬂammatory cytokines were detected in CNS tissue and cer-
ebrospinal ﬂuid (CSF) of A20Cx3Cr1-KO relative to littermate
A20FL mice after systemic LPS challenge (Fig. 3g and Supple-
mentary Fig. 8b–d). Finally, microglia from LPS-injected
A20Cx3Cr1-KO and A20FL control mice were isolated and global
gene expression was determined by RNA sequencing. Investiga-
tion of the gene ontology enrichment network on differentially
expressed genes revealed that inﬂammatory pathways are highly
affected in LPS-stimulated microglia compared with unstimulated
microglia, as expected. However, 2774 genes were differentially
expressed between A20Cx3Cr1-KO and control microglia isolated
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Fig. 3 A20Cx3Cr1-KO mice are hypersensitive to LPS. a Rectal body temperature responses and b survival were analyzed in function of time in control
(A20FL; n= 13) and A20Cx3Cr1-KO (n= 14) mice after intraperitoneal injection of 3.5 mg/kg LPS. The combined results of three independent experiments
are shown. Body temperature data are means ± SEM. Statistical differences were determined by a REML analysis for rectal body temperatures and a
Mantel–Cox test for the survival curve (**p < 0.01, ***p < 0.001). c Immunohistochemistry images showing Iba-1+ expression in the cerebral cortex,
hippocampus and spinal cord of control (A20FL) and A20Cx3Cr1-KO mice 10 h post LPS challenge. Scale bars represent 100 µm (cortex and hippocampus)
and 200 µm (spinal cord), insert: 10 and 20 µm, respectively. Representative images are displayed. Data are representative of two independent
experiments. d Number of Iba-1+ ramiﬁed parenchymal microglia in brain. Each symbol represents data from one mouse, n= 4 per group. Data are
presented as mean ± SEM. Signiﬁcant differences were determined by a two-way ANOVA with Tukey correction for multiple comparison (*p < 0.05, ****p
< 0.0001). e, f Three-dimensional reconstruction (scale bars represent 10 µm, e) and Imaris-based semiautomatic quantiﬁcation of cell morphology (f) of
cortical Iba-1+ microglia. Each symbol represents the average of three measured cells per mouse; n= 5 per group. Data are presented as mean ± SEM.
Signiﬁcant differences were determined by two-way ANOVA with Tukey correction for multiple comparison (**p < 0.01, ***p < 0.001, ****p < 0.0001).
g Bioplex analysis of cytokine levels in CSF 10 h post LPS. Each symbol represents one mouse. Data are representative of three independent experiments.
Signiﬁcant differences were determined by a one-way ANOVA with Tukey correction for multiple comparison (**p < 0.01, ****p < 0.0001). h RNA prepared
from FACS-sorted microglia from control (A20FL) and A20Cx3Cr1 mice either or not injected with LPS for 10 h was submitted for RNA sequencing. Heat
map of expression values for inﬂammatory genes that are upregulated in LPS-stimulated A20Cx3Cr1 microglia compared with LPS-stimulated control
microglia. Each column represents microglia data from one individual mouse, with four or ﬁve mice per group. Color code presents linear scale
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10 h after systemic LPS injection (cut-off: p < 0.01 and at
fold change ≥4; 1609 upregulated, 1165 downregulated in
A20Cx3Cr1-KO compared with control), and LPS-stimulated
A20Cx3Cr1-KO microglia expressed much higher levels of
inﬂammatory cytokine and chemokine pathways compared with
LPS-stimulated control microglia, demonstrating their hyper-
activation (Fig. 3h and Supplementary Fig. 9a–c). In agreement,
the homeostatic gene signature of LPS-stimulated microglia is
strongly and signiﬁcantly suppressed compared with non-
stimulated microglia (Supplementary Fig. 9d). Together, these
results demonstrate that A20 expression in microglia controls
inﬂammatory CNS responses and is essential to prevent a detri-
mental response to LPS-induced neuroinﬂammation.
Nlrp3 inﬂammasome hyperactivation in A20-deﬁcient micro-
glia. An inﬂammatory cytokine that was signiﬁcantly upregulated
in microglia from LPS-stimulated A20Cx3Cr1-KO mice and can be
detected in the CSF of A20Cx3Cr1-KO mice was IL-1β (Fig. 3g, h).
LPS induced a strong upregulation of pro-IL-1β in both control
and A20Cx3Cr1-KO microglia compared with non-injected mice,
however, this upregulation is signiﬁcantly stronger in microglia
from LPS-injected A20Cx3Cr1-KO mice compared with LPS-
a
d
Actin
Procaspase-1
p20 caspase-1
50 -
20 -
43 -
A20FL A20Cx3cr1-KO
A20FL A20Cx3cr1-KO
A20FL6000
4000
2000
R
el
at
iv
e 
ex
pr
es
sio
n
50
40
30
20
10
0
Un
stim
ula
ted
Un
stim
ula
ted
Un
stim
ula
tedAT
P
AT
P
Nig
eri
cin
Sil
icaLP
S
LP
S
A20Cx3Cr1-KO
0 ATP (min)
f
LP
S 
+ 
AT
P
LP
S 
+ 
AT
P 
+ 
DM
SO
LP
S 
+ 
AT
P 
+ 
TP
CA
-1
Un
st
im
ul
at
ed
LP
S 
+ 
AT
P
LP
S 
+ 
AT
P 
+ 
DM
SO
LP
S 
+ 
AT
P 
+ 
TP
CA
-1
Un
st
im
ul
at
ed
Actin
Procaspase-1
p20 caspase-1
50 -
20 -
43 -
b
e
c
**
*
*
*
*
* 2500
2000
IL
1β
 
(pg
/m
l)
IL
1β
 
(pg
/m
l)
IL
18
 (p
g/m
l)
1500
1000
500
600
400
200
0
100
80
60
40
20
0
100
80
60
40
20
0
0 20 40 60 80 100 120
Time (min)
0
A20FL
A20Cx3Cr1-KO
A20FL
A20Cx3Cr1-KO
A20FL
A20Cx3Cr1-KO
A20FL
A20FL LPS + ATP
A20Cx3Cr1-KO
A20Cx3Cr1-KOLPS + ATP
 
LP
S +
 AT
P
Un
stim
ula
ted LP
S
 
LP
S +
 AT
P
 
LP
S +
 AT
P +
 TP
CA
1
DM
SO
Pe
rc
et
ag
e 
ce
ll d
ea
th
(S
yto
x G
ree
n u
pta
ke
)20 40 0 20 40
Fig. 4 A20Cx3Cr1-KO microglia are hypersensitive to Nlrp3 inﬂammasome activation. a IL-1β mRNA expression in microglia from A20Cx3Cr1-KO mice
compared with control mice either or not injected with LPS. Data are presented as mean ± SEM. Signiﬁcant differences were determined by a
Mann–Whitney t-test (*p < 0.05, **p < 0.01). b IL-1β and IL-18 protein levels in the supernatant of primary cultured microglia stimulated with LPS alone or
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A20Cx3Cr1-KO mice. Data are representative of three independent experiments. c Immunoblot for procaspase-1 and cleaved caspase-1 (p20) in primary
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of two independent experiments. d Pyroptosis induction in primary microglia from control (A20FL) and A20Cx3Cr1-KO mice stimulated with LPS and ATP, as
measured by Sytox Green uptake. Data are presented as mean ± SEM and are representative of two independent experiments. Signiﬁcant differences were
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injected control mice (Fig. 4a). IL-1β is the prototype cytokine
secreted by cells upon activation of inﬂammasomes, multi-protein
complexes that enable the activation of caspase-1 leading to the
processing and secretion of biologically active IL-1β24. Also IL-18
is produced through the activation of inﬂammasomes24, however,
no difference in IL-18 expression could be observed between
FACS-sorted microglia from LPS-injected A20Cx3Cr1-KO and
control mice. Microglia are capable of engaging different
inﬂammasome types in response to infectious agents and host-
derived danger signals that are associated with neurological dis-
eases25. To study the contribution of inﬂammasome signaling to
inﬂammatory responses of A20Cx3Cr1-KO microglia, we assessed
caspase-1 processing in primary cultured microglia isolated from
A20Cx3Cr1-KO and control littermate mice. Secreted levels of IL-
1β and IL-18 were signiﬁcantly increased in LPS-primed
A20Cx3Cr1-KO microglia that were treated with soluble (ATP
and nigericin) or crystalline (silica) stimuli of the Nlrp3 inﬂam-
masome compared with control microglia (Fig. 4b). In accor-
dance, caspase-1 autoprocessing was substantially increased in
A20Cx3Cr1-KO relative to control microglia (Fig. 4c and Supple-
mentary Fig. 10a). Similarly, caspase-1 processing and IL-1β/IL-
18 secretion were also increased in A20Cx3Cr1-KO microglia
primed with the TLR2 agonist Pam3CSK4 and treated with ATP
(Supplementary Fig. 10b, c). Besides their roles in maturation and
secretion of IL-1β and IL-18, a major effector mechanism of
inﬂammasomes is the induction of pyroptosis, a pro-
inﬂammatory and lytic mode of cell death occurring mainly in
myeloid cells including microglia25. Pyroptosis induces cell
swelling and rupture of the plasma membrane, causing massive
leakage of cytosolic contents provoking inﬂammatory reactions.
Similarly to the effect on caspase-1 autoprocessing and IL-1β/IL-
18 secretion, the induction of cell death was also enhanced in
A20Cx3Cr1-KO microglia (Fig. 4d and Supplementary Fig. 10d).
Activation of the Nlrp3 inﬂammasome, one of the most pleio-
tropic inﬂammasomes, requires a priming signal that results in
the upregulation of Nlrp3 expression along with the inﬂamma-
some substrate pro-IL-1β via the pro-inﬂammatory transcription
factor NF-κB26. A20 negatively regulates Nlrp3 inﬂammasome
signaling by suppressing NF-κB-dependent production of Nlrp3
and pro-IL-1β in macrophages27. Indeed, a pharmacological
inhibitor of IKK2 (inhibitor of NF-κ-B2), TPCA-1, signiﬁcantly
reduced ATP-induced caspase-1 autoprocessing and IL-1β
secretion in LPS-primed A20Cx3Cr1-KO microglia (Fig. 4e, f and
Supplementary Fig. 10e). Together, these results demonstrate that
A20 negatively controls Nlrp3 inﬂammasome priming and acti-
vation in microglia.
Mice with A20-deﬁcient microglia are hypersensitive to
experimental autoimmune encephalomyelitis (EAE). Based on
our results, we investigated the microglia-speciﬁc function of A20
in a model of autoimmune CNS inﬂammation, namely EAE.
A20Cx3Cr1-KO and control mice were immunized with a myelin
oligodendrocyte glycoprotein (MOG) peptide (MOG35-55) and
disease progression was monitored by assessing clinical disease
symptoms and body weight (Fig. 5a, b). Both A20Cx3Cr1-KO and
control mice developed EAE, however, A20Cx3Cr1-KO mice
developed earlier disease onset and exhibited a more severe dis-
ease course as compared with control mice (Fig. 5a, b and
Table 2), demonstrating a crucial role for microglial A20 activity
in EAE pathogenesis. In contrast, A20 deletion in other CNS cell
types (all CNS progenitor cells, neurons, astrocytes, or oligo-
dendrocytes) did not result in differences in EAE clinical
pathology (Supplementary Fig. 11a). Clinical pathology in
A20Cx3Cr1-KO was conﬁrmed by histology and ﬂow cytometry on
spinal cord sections at start of the clinical manifestations, showing
extensive demyelination, axonal damage, inﬂammation and
immune cell inﬁltration in A20Cx3Cr1-KO mice, while nearly no
immune cell inﬁltration, demyelination, or axonal loss could be
detected in the spinal cord of control mice at this early time point
(Fig. 5c, d, Supplementary Fig. 11b). Also the expression of
inﬂammatory cytokines, chemokines and TH1-, TH17-, and
Treg-linked factors, conﬁrmed the hypersensitivity of A20Cx3Cr1-
KO mice to EAE (Supplementary Fig. 11c). Although, the Cx3Cr1
promoter is not thought to target lymphocytes in Cx3Cr1CreErt2
mice, we conﬁrmed that the enhanced sensitivity in EAE was
caused by the CNS-speciﬁc ablation of A20 and not by an
impaired peripheral T-cell response. Lymphocytes from immu-
nized mice were isolated and tested in vitro for their response
upon secondary exposure to MOG35–55 peptide, showing similar
responses in A20Cx3Cr1-KO and control mice, thereby demon-
strating that peripheral immune functions are not affected in
A20Cx3Cr1-KO mice (Supplementary Fig. 11d). As A20 deﬁciency
enhances the activation of the Nlrp3 inﬂammasome in isolated
primary microglia (Fig. 4), we speculated that the hyperactivation
of the Nlrp3 inﬂammasome is responsible for the aggravated EAE
phenotype in A20Cx3Cr1-KO mice. Indeed, gene expression ana-
lysis of spinal cord tissue showed enhanced expression of pro-IL-
1β, ASC, Nlrp3, and caspase-1 in A20Cx3Cr1-KO mice compared
with control mice, suggesting a contribution of inﬂammasome
activities in the observed phenotype (Fig. 5e). To test this
hypothesis, Nlrp3−/− mice were crossed with A20Cx3Cr1-KO mice
and EAE disease development was monitored. In contrast to
A20Cx3Cr1-KO mice, which develop a more severe pathology,
A20Cx3Cr1-KO-Nlrp3−/− mice show a signiﬁcantly reduced clin-
ical pathology, comparable to control A20FL littermate mice
(Fig. 5f). These results are in line with previous studies demon-
strating a critical role for Nlrp3 in the development of EAE by
mediating peripheral immune responses28–30. However, Nlrp3
−/− mice lack the Nlrp3 protein ubiquitously, and the speciﬁc
contribution of inﬂammasome signaling inside the CNS to EAE
pathogenesis is unknown. To study the speciﬁc function of
inﬂammasomes within microglia during EAE, caspase-1 condi-
tional knockout mice having a ﬂoxed allele (caspase-1FL) were
generated31 (Supplementary Fig. 12a) and crossed with
A20Cx3Cr1-KO mice to produce mice lacking both A20 and
caspase-1 in microglia (caspase-1-A20Cx3Cr1-KO). In contrast to
single A20Cx3Cr1-KO mice, caspase-1/A20Cx3Cr1-KO mice devel-
oped less severe disease upon immunization with MOG35–55
peptide (Fig. 5g). However, caspase-1-A20 double deﬁcient
microglia still display an inﬂammatory phenotype, similar to A20
knockout microglia (Supplementary Fig. 12b), suggesting that
downstream effectors other than caspase-1 contribute to inﬂam-
matory gene upregulation. Together, these results demonstrate
the role of A20 in the control of Nlrp3 inﬂammasome activation
locally in microglia, and indicate the importance of this microglial
A20/Nlrp3 inﬂammasome axis in EAE pathogenesis.
Finally, to investigate the relevance of our ﬁndings to human
CNS pathology, postmortem brain tissue and CSF of multiple
sclerosis (MS) patients (Supplementary Table 3) were analyzed
for expression of A20 and for the presence of an inﬂammasome
“signature.” Expression of A20/TNFAIP3, as well as the expres-
sion levels of IL-1β and NLRP3 were signiﬁcantly increased in MS
plaques compared with normal appearing white matter, and a
trend, albeit not signiﬁcant, in enhanced IL-18 and caspase-1 in
MS plaques could be observed (Fig. 6a, b). Higher IL-18 and IL-
1β protein levels were also detected in CSF of MS patients
compared with controls, suggestive of inﬂammasome activation
in microglia, although also other immune cells may have
contributed to this (Fig. 6c). Our data analyzing the expression
levels of inﬂammasome mediators in brain plaques isolated from
normal and MS patients show that brain tissue affected by MS
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clearly exhibits enhanced activation of the NLRP3 inﬂammasome,
as shown in previous studies.
Discussion
In this study, we identiﬁed A20 as a crucial mediator of microglia
activation, synaptic function, and EAE pathogenesis. In contrast
to its expression in neurons, astrocytes, oligodendrocytes (both
precursor and mature myelinating), and brain endothelial cells,
A20 is highly expressed in adult microglia9. Mice lacking
A20 speciﬁcally in microglia have increased total numbers of
microglia, in the absence of any overt abnormalities. Detailed
morphometric analysis, as well as transcriptome analysis of
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microglia from A20-deﬁcient mice revealed an altered microglia
phenotype. In agreement, our expression study revealed an
inﬂammatory “signature” of these steady-state A20-deﬁcient
microglia, demonstrated by the upregulation of many inﬂam-
matory genes and pathways. Also many DAM markers, including
apolipoprotein A (Apoe), are signiﬁcantly upregulated in A20-
deﬁcient microglia, a feature that has been linked to a disease-
associated phenotype14,15. In agreement, A20-deﬁcient microglia
display a suppressed “homeostatic gene signature”, a signature
also reminiscent of microglia in neurodegenerative condi-
tions14,32,33. Besides their microglia phenotype, A20Cx3Cr1-KO
mice also demonstrate an aberrant molecular signature in its
other CNS tissue macrophages, although less pronounced com-
pared with microglia, in agreement with our recent ﬁnding that
these macrophages share their origin and cellular dynamics with
microglia7.
Our studies demonstrate that layer V pyramidal neurons from
microglia A20 knockout mice show a strong and signiﬁcant
increase in sEPSC frequency, suggesting an increase in cortical
dendritic spine number. Previous studies already indicated that
alterations in microglial number or activation can result in
functional and structural changes in cortical circuits. Activation
of microglia by LPS was shown to increase the frequency of
sEPSC18, while ablation of microglia results in a decrease in spine
density with a corresponding reduction in miniature excitatory
postsynaptic current (mEPSC) frequency16. Moreover, microglia
depletion results in defects in learning-induced dendritic spine
remodeling, with corresponding decreases in mEPSC frequency
in layer V pyramidal neurons in S1 cortex17. Whether the
synaptic phenotype in mice with microglia A20 deﬁciency
impacts on the normal development of these mice is currently
unclear, but our studies indicate that it may have consequences
for normal memory and cognition. However, additional studies
are required, especially since microglia activation and synaptic
and cognitive dysfunction are symptoms of many neurological
pathologies.
In pathological conditions, microglia are known to respond by
redirecting their physiological functions and inducing the acti-
vation of inﬂammatory pathways contributing to the progression
of disease1. Here we show that mice lacking expression of A20 in
microglia are highly sensitive to the development of inﬂammatory
CNS pathology. Mechanistically, this hyperinﬂammatory condi-
tion is caused by overactivation of the Nlrp3 inﬂammasome in
A20-deﬁcient microglia, identifying A20 as a brake on microglial
Nlrp3 inﬂammasome activation and neuroinﬂammation. This
observation is reminiscent of our previous studies demonstrating
that A20 deletion in macrophages induces excessive NF-κB-
dependent Nlrp3 inﬂammasome activation27. Mice with myeloid
A20 deﬁciency develop a severe destructive polyarthritis34, which
can be rescued in a Nlrp3-deﬁcient background27. Interestingly, a
recent genetic study identiﬁed loss-of-function mutations in
the A20/TNFAIP3 gene in humans causing early-onset autoin-
ﬂammation. Peripheral blood mononuclear cells derived from
these patients showed constitutive activation of the NLRP3
inﬂammasome resulting in increased secretion of active IL-1β and
IL-18, suggesting that NLRP3 hyperactivation drives pathology in
these patients35. In our study, we now show that A20 expression
in microglia critically controls inﬂammasome activation and CNS
inﬂammation in the EAE mouse model of MS. However, since
also non-parenchymal CNS macrophages lack A20 expression,
these may also have contributed to the increased EAE pathology.
Indeed, because of their strategic position at CNS barriers,
meningeal, perivascular, and choroid plexus macrophages might
modulate immune cell entry and hence be involved in various
neuroinﬂammatory processes36. New strategies allowing to spe-
ciﬁcally target the different CNS macrophage populations will be
needed in order to identify their particular function and the role
of A20 in CNS homeostasis and pathology.
Absence of A20 in microglia strongly sensitized mice to EAE,
associated with severe CNS inﬂammation, demyelination, and
tissue damage. This clinical phenotype could be reversed in
conditions where inﬂammasome activation in microglia was
prevented, identifying the Nlrp3 inﬂammasome in microglia
central to MS pathology. A number of reports already suggested
the involvement of inﬂammasomes in the development of MS37.
Levels of IL-1β and IL-18 are upregulated in CSF and peripheral
blood mononuclear cells of MS patients, and both cytokines have
been shown to inﬂuence disease development in EAE. Expression
of caspase-1 is elevated in MS plaques, and ATP, as well as uric
acid, both activators of the NLRP3 inﬂammasome are upregu-
lated in the CSF of MS patients37. Experimental studies using
knockout mice have shown that the induction of EAE, T-cell
priming, and trafﬁcking into the CNS, is dependent on the
NLRP3 inﬂammasome30,38. However, the cell types responsible
for destructive inﬂammasome responses within the CNS had not
Table 2 Clinical features of MOG35–55-induced EAE in A20FL
and A20Cx3Cr1KO littermates showing disease incidence (at
least a score of 2), day of onset and mean maximal clinical
score
Genotype Incidence Day of onset (p
< 0.001)
Mean-max score
(p= 0.012)
A20FL 100% (6/6) 16.2 ± 0.5 2.8 ± 0.3
A20Cx3Cr1-KO 100% (10/10) 11.9 ± 0.3 3.9 ± 0.2
Results are displayed as mean ± SEM
Fig. 5 Microglia A20 deﬁciency aggravates autoimmune CNS inﬂammation due to Nlrp3 inﬂammasome hyperactivation. a, b EAE was induced by active
immunization of control A20FL (n= 6) and A20Cx3Cr1-KO mice (n= 10) with MOG peptide, and clinical disease development (a) and body weight (b) was
followed over time. Each data point represents the mean ± SEM as estimated by the REML analysis. Changes in clinical score and relative body weight differ
signiﬁcantly (***p < 0.001; F-test) between genotypes across the time span. Data are representative of three independent experiments. c Representative
images of spinal cord of control (A20FL) and A20Cx3Cr1-KO mice 13 days post immunization using LFB, APP, CD3, and MAC-3 antibodies. Scale bars
represent 200 µm (overview) and 20 µm (zoom). Representative images from at least four mice per group are displayed. d Assessment of immune cell
(CD3, CD4, and CD8 T cell, Treg) inﬁltration in the CNS of control (A20FL) and A20Cx3Cr1-KO mice by ﬂow cytometry just before disease onset. Each
symbol represents one mouse. Data are expressed as mean ± SEM and signiﬁcant differences are determined by a Mann–Whitney U-statistical test (***p <
0.001, ****p < 0.0001). e Expression of inﬂammasome-associated factors in the spinal cord of TAM-injected control (A20FL) and A20Cx3Cr1-KO mice
12 days post immunization. Each symbol represents one mouse. Data are expressed as the ratio of the mRNA expression normalized to endogenous
housekeeping genes and expressed as mean ± SEM. Signiﬁcant differences are determined by a Mann–Whitney U-statistical test (****p < 0.0001). f, g
Active immunization of control (A20FL, n= 11), A20Cx3Cr1-KO (n= 10), Nlrp3KO (n= 18), and A20Cx3Cr1-KO-Nlrp3KO (n= 8) mice (f) and of control
(A20FL, n= 28), A20Cx3Cr1-KO (n= 15) and A20/caspase-1Cx3Cr1-KO (n= 13) mice (g), and clinical disease development over time. Each data point
represents the mean ± SEM as estimated by the REML analysis. Changes in clinical score and relative body weight differ signiﬁcantly between genotypes
across the time span (*p < 0.05, **p < 0.01, ***p < 0.001; F-test). Graph represents combined data from three independent experiments
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been investigated in MS models so far, and speciﬁcally their role
in microglia was not clear. Our ﬁndings now demonstrate that a
mechanism through which A20 mediates its protective effects
locally in the CNS is by controlling the activation of the Nlrp3
inﬂammasome in microglia, thereby preventing release of pro-
inﬂammatory cytokines IL-1ß and IL-18. This cytokine micro-
environment is thought to be crucial in autoimmune CNS
inﬂammation by potentiating the local immune response inside
the CNS39. Moreover, inﬂammatory cytokines, including IL-1ß
have the potential to affect synaptic transmission, and synaptic
alterations have been demonstrated in neuroinﬂammatory dis-
eases including MS40. Since our ﬁndings demonstrate an
important role for A20 in the control of inﬂammasome activation
within microglia during EAE, this could imply a general
mechanism controlling inﬂammatory reactions also in other
neurodegenerative conditions. In this context, inﬂammasome
activation has recently been shown to be involved in the
pathology of Alzheimer disease41, amyotrophic lateral sclerosis42,
and Parkinson’s disease43, although the speciﬁc role of microglial
inﬂammasome activation in these neurodegenerative diseases
awaits analysis.
Finally, in contrast to an important function for A20 in
microglia, we could not demonstrate an important role for A20 in
other neuronal cell types in the model of EAE, contrary to a
previous study suggesting a role for A20 in astrocytes44.
Although, the reasons for the different disease phenotypes are
unknown, differences in the technical methodologies, mouse
genetic backgrounds, and/or microbiota composition might have
contributed to the differential outcomes between the studies.
Spontaneous neuroinﬂammation characterized by reactive
microgliosis, astrogliosis, and inﬂammatory cytokine secretion in
the brain has previously been reported in A20 full knockout
mice45. However, these mice are severely diseased and display a
hyperinﬂammatory phenotype in nearly all tissues examined,
including the brain46. Because of this severe lethal inﬂammatory
phenotype, microglia-speciﬁc A20 targeting is essential to inves-
tigate the speciﬁc contribution of A20 in microglia homeostasis
and pathology.
In summary, we found that A20 critically controls microglia
activation both in steady-state as in conditions of neuroin-
ﬂammation. In experimental models of neuroinﬂammation, the
expression of A20 by microglia is crucial in keeping NLRP3
inﬂammasome activation at bay. These results may contribute to
a better understanding and treatment of inﬂammatory and neu-
rodegenerative diseases. Strategies targeting microglia to suppress
their activation eventually through expression of A20 might prove
useful for the treatment of these diseases.
Methods
Animals. Conditional A20 knockout mice harboring two loxP sequences ﬂanking
exons 4 and 5 (A20FL/FL) were generated as previously described10. A20FL/FL mice
were crossed with Cx3Cr1Ert2-Cre transgenic mice5 to generate A20Cx3Cr1KO
mice. A20FL/FL mice were crossed with Nestin-Cre47, Thy1.2-Cre48, GFAP-Cre49,
or MOGi-Cre50 transgenic mice to generate A20CNS-KO, A20Neur-KO, A20ASTR-KO,
or A20ODC-KO mice, respectively. Nlrp3 knockout mice have been described51, and
caspase-1FL/FL mice have been generated using European Conditional Mouse
Mutagenesis Program ES cells31. R26-YFP reporter mice were obtained from The
Jackson Laboratory (B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J). All experiments
were performed on mice backcrossed into the C57BL/6 genetic background for at
least six generations. Mice were housed in individually ventilated cages in either
speciﬁc pathogen-free or conventional animal facilities. All experiments on mice
were conducted according to institutional, national, and European animal reg-
ulations. Animal protocols were approved by the ethics committee of Ghent
University.
Histological analysis. Mice were transcardially perfused with PBS containing
5 IU/ml heparin (De Pannemaeker, Ghent, Belgium), followed by perfusion with
4% paraformaldehyde. Brain and spinal cord tissue were dissected, dehydrated, and
embedded in parafﬁn blocks. Alternatively, for vibratome sections brains were
stored in low-melting agarose until further processing. Sections of 5 µm were
stained with Luxol fast blue (Solvent Blue 38, practical grade; Sigma Genosys) for
assessment of demyelination, or incubated with antibodies against CD3 (clone
CD3–12; Serotex), Mac-3 (clone CD107b, M3/84; Becton Dickinson Biosciences),
B220 (clone RA3-6B2; Becton Dickinson Biosciences), amyloid precursor protein
(APP; clone 22C11; Millipore), Iba-1 (Wako Chemicals), or Ki67 (clone D3B5; Cell
Signaling). Sections were rehydrated and incubated in antigen retrieval buffer
(Dakopatts). Endogenous peroxidase activity was blocked by immersing slides in
3% H2O2. Nonspeciﬁc binding was blocked by incubating sections in 5% NGS and
0.1% Triton X-100. Primary antibodies were incubated overnight at 4 °C.
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Fig. 6 Enhanced A20 expression and NLRP3 inﬂammasome activation in
human MS samples. a, b Relative gene expression levels of A20/TNFAIP3
(a) and of inﬂammasome-associated factors (b) in plaques of postmortem
MS patients (plaque) or postmortem control tissue (NAWM). Each symbol
represents one patient. Data are expressed as the ratio of the mRNA
expression normalized to endogenous housekeeping genes (Sdha and Tbp)
and expressed as mean ± SEM. Signiﬁcant differences are determined by
Mann–Whitney U-statistical test (*p < 0.05, **p < 0.01). c IL-1β and IL-18
cytokine levels in the CSF of postmortem MS patients or control samples.
Each symbol represents one CSF sample. Signiﬁcant differences are
determined by Mann–Whitney U-statistical test (*p < 0.05)
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Immunoﬂuorescence microscopy, microglia quantiﬁcation, and 3D recon-
struction. Fluorescence microscopy was performed using a confocal spinning disk
microscope (Zeiss, Germany). Double-positive cells (Ki67+ and Iba-1+ positive)
were counted on 6–12 representative images (267.20 × 267.73 µm) for each sample
and an average was calculated. Bright-ﬁeld microscopy was done using an olympus
light microscope (BX51) and with a Axio Scan.Z1 (Zeiss, Germany). For 3D
reconstruction of microglia, 70-μm vibratome sections from adult brain tissue were
stained overnight with anti-Iba-1 (1:500) at 4 °C, followed by Dylight 594-
conjugated secondary antibody (1:1000) overnight at 4 °C. Nuclei were counter-
stained with Hoechst. Confocal images were taken with a Leica Sp5 AOBS confocal
microscope (Leica, Mannhein, Germany), using a HCX PL APO CS 40.0 × 1.25 UV
oil objective. Three cells per mouse and ﬁve mice per condition were reconstructed.
For live cell imaging, primary cultured microglia were seeded in an eight-well
chamber (iBidi). Cell death was monitored by propidium iodide (PI) or Sytox
Green uptake. Live cell imaging was performed on a Zeiss confocal spinning disk
(Zeiss, Germany). Analysis was performed on Fiji, a public domain imaging
software.
RNA-seq. RNA-seq was performed on FACS-sorted CD45intCD11b+ microglia or
CD45hiCD11b+CD206+ macrophages obtained from TAM-injected A20FL and
A20Cx3Cr1-KO mice. A total of 200,000 cells, stained with antibodies against CD11b,
CD45, Gr1 and CD206 (eBioscience)52 per brain were sorted in 1 ml RNAprotect
cell reagent (Qiagen) and total RNA was subsequently isolated by column pur-
iﬁcation (RNeasy Plus Micro Kit, Qiagen). Generation of cDNA (Clontech
SMARTer Ultra Low RNA Kit v4) and library preparation (Illumina NexteraXT
custom small-sample protocol) were performed according to manufacturer’s pro-
tocols. The sequencing libraries were sequenced on an Illumina HiSeq
1000 sequencer. Basecalling and Fastq ﬁle generation was performed using stan-
dard Illumina software (RTA, Casava). Fastq ﬁles were analyzed for data quality
using FastQC v0.11.553. FastQC: a quality control tool for high-throughput
sequence data. Available online at: http://www.bioinformatics.babraham.ac.uk/
projects/fastqc. Sequences were aligned to the mouse genome assembly GRCm38 as
provided by the GENCODE project54 using the Star aligner v2.5.2b55. Aligned
reads were counted using featureCounts v1.5.156. Differential gene expression
analysis followed the limma/voom pipeline (limma v3.30)57. Pathway analysis was
carried out using IPA (Qiagen). Illumina deep sequencing was performed at a
genomics core facility: Center of Excellence for Fluorescent Bioanalytics (KFB,
University of Regensburg, Germany). All RNA-seq datasets are accessible under
GEO accession number GSE107733.
Electrophysiology. Mice were injected with TAM at weaning age and acute cor-
onal slices from postnatal days 30–35 were cut on a Leica VT1200 vibratome. Mice
were deeply anesthetized with isoﬂuorane and rapidly decapitated. A length of 300-
µm-thick slices were cut in a sucrose-based cutting solution (ACSF) that consisted
of 87 mM NaCl, 25 mM NaHCO3, 10 mM Glucose, 75 mM Sucrose, 2.5 mM KCl,
1.25 mM NaH2PO4, 0.5 mM CaCl2, 7 mM MgCl2, 1 mM kynurenic acid, 5 mM
ascorbic acid, and 3 mM pyruvic acid. Slices were allowed to recover at 34 °C for
30 min, and then maintained at room temperature in the same solution for at least
30 min before use. During recordings, slices were perfused at 1–2 mL/min with
ACSF consisting of 119 mM NaCl, 2.5 mM KCl, 1 mM NaH2PO4, 11 mM glucose,
26 mM NaHCO3, 4 mM MgCl2, 4 mM CaCl2, and 0.1 mM picrotoxin (to block
inhibitory currents) bubbled continuously with 95% O2 and 5% CO2. Layer V
pyramidal neurons in somatosensory cortex were visualized by infrared differential
interference (Zeiss Axio Examiner.A1). Whole-cell voltage (Vhold =−70 mV) and
current clamp recordings were made. Electrode resistances ranged from 3 to
5.5 MΩ. Pipettes were pulled on a horizontal micropipette puller (Sutter P-1000)
and ﬁlled with a K-gluconate-based internal solution consisting of 135 mM K-
Gluconate, 4 KmM Cl, 2 mM NaCl, 10 mM HEPES, 4 mM EGTA, 4 mM Mg ATP,
0.3 mM Na GTP, adjusted to pH 7.25 and 295 mOsm. For all recordings, the
number of experiments (n) reported in the ﬁgure legends refer to the number of
cells, while (m) refers to the number of animals used in the experiment. sEPSCs
were analyzed using the Mini Analysis program (Synaptosoft). Action potential
(AP) proﬁling was assessed by injecting current in 50 pA steps starting at −150 mV
until 850 pA. Whole-cell voltage clamp recordings were gained 5–20-fold, low-pass
ﬁltered at 1 kHz, and digitized at 3 kHz (Molecular Devices DigiData 1440A and
Multiclamp 700B). Input resistance (Rin), pipette series resistance (Rs), and
membrane holding current were monitored throughout all recordings to ensure
stability and quality. Recordings were made at 34 °C.
Behavioral test. Spatial learning and cognitive ﬂexibility was examined in the
hidden platform MWM19,20,58. A circular pool (diameter 150 cm) was ﬁlled with
tempered water (26 ± 1 °C), opaciﬁed by adding nontoxic white paint. The platform
(diameter, 15 cm) was hidden 1 cm underneath the water surface. The location of
the platform remained the same throughout the 10 days of spatial acquisition, was
relocated to the opposite quadrant during the 5 days of reversal learning trials and
removed during probe trials. Female A20Cx3Cr1-KO and control littermate mice
were trained daily in four sequential sessions (15–30 min interval) starting ran-
domly from one of four starting positions. Animals that were not able to ﬁnd the
platform within 120 s, were gently guided to the platform where they remained for
15 s before they were transferred to their home cage. Probe trials were conducted
on days 6 and 11 during acquisition learning and on day 6 of reversal learning.
EthoVision video tracking equipment and software (Noldus, Wageningen, The
Netherlands) were used to quantify and extract swim paths parameters.
Systemic and icv LPS injection and CSF isolation. Female mice received an
intraperitoneal injection of 3.5 mg/kg LPS (LPS-EB Ultrapure, Escherichia coli
0111:B4 from Invivogen) in PBS. Body temperature and survival were monitored
every hour after LPS challenge. CSF was isolated from the fourth ventricle using the
cisterna magna puncture method59. For icv injection of LPS, mice were anaes-
thetized with isoﬂurane and mounted on a stereotactic frame. A constant body
temperature of 37 °C was maintained using a heating pad. Injection coordinates
were measured from the bregma (anteroposterior 0.07, mediolateral 0.1, dorso-
ventral 0.2) and lambda. These coordinates were determined using the Franklin
and Paxinos mouse brain atlas. A Hamilton needle was used to inject 4 μl LPS
(0.25 μg/μl) into the left lateral ventricle of the brain.
Induction and assessment of EAE. Eight- to 15-week-old male littermate mice
were immunized subcutaneously with an emulsion of 200 µg MOG35–55 (MEVG-
WYRSPFSRVVHLYRNGK) peptide in 100 µl sterile PBS and an equal volume of
CFA (Sigma-Aldrich) supplemented with 10 mg/ml Mycobacterium tuberculosis
H37RA (Becton Dickinson Bioscience). Mice also received 50 ng of pertussis toxin
(Sigma-Aldrich) in 200 µl sterile PBS at the time of immunization and 48 h later.
Clinical signs of disease were scored on a scale of 0–5, with 0.5 points for
immediate clinical ﬁndings as follows: 0, normal; 1, weakness of tail; 2, complete
loss of tail tonicity; 3, partial hind limb paralysis; 4, complete hind limb paralysis; 5,
forelimb paralysis or moribund. To eliminate any diagnostic bias, mice were scored
blindly.
T-cell recall assay. Ten days post immunization with MOG35–55 peptide, spleens
were isolated. Erythrocytes were lysed using ACK lysis buffer and splenocytes were
cultured in 96-well plates at a density of 7 × 105 cells/well in DMEM supplemented
with 5% FCS, L-glutamine, nonessential amino acids (NEAA) and penicillin/
streptadivin antibiotics. Cells were then treated with either no, 1, 10, or 30 µg/ml
MOG35–55 peptide. After 48 h, supernatant was collected and concentrations of IL-
2 and IFNγ were determined by ELISA (eBioscience, San Diego, CA, USA).
Quantitative real-time PCR on mouse tissue. Total RNA was isolated using
TRIzol reagent (Invitrogen) and an Aurum Total RNA Isolation Mini Kit (Bio-
Rad), according to manufacturer’s instructions. Synthesis of cDNA was performed
using an iScript Advanced cDNA synthesis kit (Bio-Rad), according to manu-
facturer’s instructions. A total of 10 ng of cDNA was used for quantitative PCR in a
total volume of 10 µl with LightCycler 480 SYBR Green I Master Mix (Roche) and
speciﬁc primers, on a LightCycler 480 (Roche). Real-time PCR reactions were
performed in triplicates. The following mouse-speciﬁc primers were used: ASC
forward, 5′-CTTGTCAGGGGATGAACTCAAAA-3′, ASC reverse, 5′-GCCA-
TACGACTCCAGATAGTAGC-3′; caspase-1 forward, 5′-ACAAGGCACGGGA-
CCTATG-3′, caspase-1 reverse, 5′-TCCCAGTCAGTCCTGGAAATG-3′; Dcaf6
forward, 5′-ACCTTTTGCCGTGTATGG AG-3′, Dcaf6 reverse, 5′-ATTGATC-
CAAGCTCCCACAG-3′; Gapdh forward, 5′-TGAAGCAGGCATCTGAGGG-3′,
Gapdh reverse, 5′-CGAAGGTGGAAGAGTGGGAG-3′; Hprt forward, 5′-AGTG
TTGGATACAGGCCAGAC-3′, Hprt reverse, 5′-CGTGATTCAAATCCCTGAA
GT-3′; Pro-IL-1β forward, 5′-TGGGCCTCAAAGGAAAGA-3′, Pro-IL-1β reverse,
3′-GGTGCTGATGTACCAGTT-3′; Nlrp3 forward, 5′-ATTACCCGCCCGAGAA
AG G-3′, Nlrp3 reverse, 5′-TCGCAGCAAAGATCCACACAG-3′; Tbet forward,
5′-AGAACGCAGAGATCACTCAG-3′, Tbet reverse, 5′-GGATACTGGTTGGA-
TAGAAGAGG-3′; IFNγ forward, 5′-GCCAAGCGGCTGACTGA-3′, IFNγ
reverse, 5′-TCAGTGAAGTAAAGGTACAAGCTACAATCT-3′; IL-2 forward, 5′-
GTGCCAATTCGATGATGAGTCA-3′, IL-2 reverse, 5′-GGGCTTGTTGA-
GATGATGCTTT-3′; GATA3 forward, 5′-GGCAGAAAGCAAAATGTTTGCT-3′,
GATA3 reverse, 5′-TGAGTCTGAATGGCTTATTCA CAAAT-3′; STAT6 for-
ward, 5′-GGGTGTTAATGCTCGAATGTGATA-3′, STAT6 reverse, 5′-CACAA
TGTCTCTATGTTTCT GTATGTTGAG-3′; IL13 forward, 5′-TCAGCCATGAA-
ATAACTTATTGTTTTGT-3′, IL13 reverse, 5′-CCTTGAGTGTAACAGGCCA
TTCT-3′; TGFβ forward, 5′-GCTGAACCAAGGAGACGGAATA-3′, TGFβ
reverse, 5′-GAGTTTGTTATCTTTGCTGTCACAAGA-3′; IL23p19 forward, 5′-
TACAGAGTTAGACTCAGAACCA-3′, IL23p19 reverse, 5′-TAGTAGATTCAT-
ATGTCCCGCTG-3′ RORγt forward, 5′-CCCCCTGCCCAGAAACACT-3′, RORγt
reverse, 5′-GGTAGCCCAGGACAGCACAC-3′; Foxp3 forward, 5′-GGCCCTTCT
CCAGGACAGA-3′, Foxp3 reverse, 5′-GCTGATCATGGCTGGGTTGT-3′; Ip10
forward, 5′-GTCACATCAGCTGCTACTC-3′, Ip10 reverse, 5′-GTGGTTAAGTT-
CGTGCTTAC-3′; IL6 forward, 5′-GAGGATACCACTCCCAACAGACC-3′, IL6
reverse, 5′-AAGTGCATCATCGTTGTTCATACA-3′ CCL2 forward, 5′-GCATCT
GCCCTAAGGTCTTCA-3′, CCL2 reverse, 5′-TGCTTGAGGTGGTTGTGGAA-3′;
Rantes forward, 5′- CGTCAAGGAGTATTTCTACAC-3′, Rantes reverse, 5′-GGT
CAGAATCAAGAAACCCT-3′; IL-1β forward, 5′-CAACCAACAAGTGATATT-
CTCCATG-3′, IL-1β reverse, 5′-GATCCACACTCTCCAGCTGCA-3′. For quan-
titative real-time PCR on human tissue, a total of 10 ng of cDNA was used with
either speciﬁc Taqman probes and TaqMan Gene Expression Master Mix (Life
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Technologies) or speciﬁc primers and LightCycler 480 SYBR Green I Master Mix
(Roche). The following human-speciﬁc primers were used: HMBS forward, 5′-
GGGTACCCACGCGAATCAC-3′, HMBS reverse, 5′-GGCAATGCGGCTGCAA-
3′; SDHA forward, 5′-CCACCACTGCATCAAATTCATG-3′, SDHA reverse, 5′-
TGGGAACAAGAGGGCATCTG-3′; Nlrp3 forward, 5′-GTCTCCGA-
GAGTGTTGCCTC-3′, Nlrp3 reverse, 5′-GGGACTGAAGCACCTGTTGT-3′.
Taqman probes for TBP (Hs00427620_m1), Caspase1 (Hs00354836_m1), IL18
(Hs01038788_m1) and IL1β (Hs01555410_m1) were from applied Biosystems.
Western blot. Cell and tissue extracts were prepared in E1A lysis buffer (250 mM
NaCl, 50 mM Tris pH 7.4, 0.1% NP-40) containing a complete protease inhibitor
cocktail (1:25) (Roche) and centrifuged for 10 min at 14.000 r.p.m. in a micro-
centrifuge at 4 °C. Supernatants were denatured in laemmli buffer, separated by
SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose and immu-
nodetected with anti-A20 (Santa Cruz Biotechnology, Inc.), anti-caspase-1 (Adi-
pogen), and anti-actin (MP Biomedicals) antibodies.
Microglia isolation for in vitro studies. Zero- to 3-day-old pups were used to
isolate microglia. Brains were isolated in F12 Nutrient Mixture Ham medium
(Gibco Life Technologies) and stripped of olfactory bulbs, cerebellum and mid-
brain, and meninges were removed. Brain tissue was digested using trypsin and
resuspended in DMEM medium supplemented with 10% FCS, 1% penicillin/
streptadivin, glutamine, sodium pyruvat, and NEAA. Cell suspensions were incu-
bated in tissue ﬂasks pretreated with poly-L-lysine. After 4–7 days, astrocytes
recovered and microglia are generated by addition of DMEM medium containing
25% of L929 conditioned medium. Three to 4 days later, microglia were isolated
from mixed glial cell cultures by shaking at 100 r.p.m. for an hour. Microglia were
resuspended in RPMI containing 25% L929 conditioned medium. To induce cre-
mediated A20 gene deletion, cells were stimulated for 3 days with 1 µM 4-
hydroxytamoxifen (Sigma). The next day, microglia were either left untreated or
treated with 5 µg/ml ultrapure LPS (E. coli 0111:B4 strain, Invivogen) for 3 h fol-
lowed by 5 mM ATP (Sigma-Aldrich) for 20 min or 20 µM nigericin (Sigma-
Aldrich) for 30 min or 0.5 mg/ml silica (Min-U-Sil 5, US Silica) for 6 h. For
inhibition of NF-κB, microglia were preincubated for 30 min with 1.25 μM of the
selective IKK2 inhibitor TPCA-160 (Sigma-Aldrich) before stimulation with LPS.
Time-lapse imaging of cell death in primary microglia was done based on PI or
Sytox Green uptake. Microglia were either left untreated or treated with 5 µg/ml
ultrapure LPS for 3 h, and imaging was started upon treatment of cells with 5 mM
ATP (Sigma-Aldrich).
Preparation of tissue samples for ﬂow cytometry. For preparation of single cell
suspensions for ﬂow cytometry, brain, liver, lung, heart, and skin tissues were cut
into small pieces. Liver, lung, and heart tissues were transferred to enzymatic
solutions (liver: 1 mg/ml collagenase D (Roche, Darmstadt, Germany); lung:
0.5 mg/ml collagenase D and heart: 1 mg/ml collagenase II supplemented with
+0.1 mg/ml DNase (Sigma-Aldrich, Taufkirchen, Germany) in HBSS for 30 min or
60 min at 37 °C, shaking). For skin samples, smashed tissue was digested using
1.5 mg/ml collagenase V (Life technologies, Darmstadt, Germany) for 1.5 h at 37 °
C. Cell suspensions were ﬁltered through a mesh (70 µm, restrictively) and cen-
trifuged for 5 min 1200 r.p.m., 4 °C. Erythrocytes were removed by RBC lysis buffer
(eBioscience, San Diego, USA). Brain tissue was homogenized and ﬁltered through
a 70 µm mesh. After centrifugation (10 min 1200 r.p.m., 4 °C) the pellet was
resuspended in 37% Percoll (Sigma-Aldrich, Taufkirchen, Germany) followed by
centrifugation; 30 min, 800×g at 4 °C without brake.
Microglia isolation. Mice were perfused with cold PBS containing 5 IU/ml heparin
and brains were isolated in 1X HBBS with 45% glucose and HEPES. Brains were
minced using a scalpel and dissociated in high-glucose DMEM medium containing
collagenase A, FCS, and DNAse I at 37 °C. Cells were isolated by centrifugation at
300×g for 10 min at 4 °C, and resuspended in 5 ml 25% Percoll and covered with
3 ml of PBS. Microglial cells are present in the pellet fraction after centrifuging at
800×g for 25 min at 4 °C, and were resuspended in FACS buffer (0.5% BSA, 2 mM
EDTA in PBS) for further analysis.
Kupffer cell isolation. Livers were ﬂushed with PBS, isolated and chopped into
small pieces. A volume of 3 ml RPMI supplemented with 1 mg/ml collagenase A
(Sigma) and 10 U/ml Dnase (Roche) was added and cells were subjected to the
GentleMACS liver 1 protocol (Miltenyi Biotec). Cells were then incubated for
20 min at 37 °C in a shaking water bath and subsequently subjected to GentleMACs
liver protocol 2 (Miltenyi Biotec). Suspensions were ﬁltered, red blood cells lysed,
and remaining cells were stained.
Flow cytometry and FACS sorting. The following antibodies were used for
staining cells: anti-CD45 (clone 30-F11, eBioscience), anti-CD11b (clone M1/70,
eBioscience), anti-CD64 (clone X54-5/7.1, Biolegend, Fell, Germany), anti-Gr1
(clone RB6-8C5, Biolegend), anti-F4/80 (clone BM8, eBioscience), anti-CD11b-
APC-Cy7 (clone M1/70, RUO Becton Dickinson Biosciences), CD11b-BV605
(Clone M1/70, Becton Dickinson Biosciences), CD3-PECy7 (Clone 17A2,
Biolegend) CD4-eFluor450 (Clone RM4-5, eBioscience), CD8-PECy5 (Clone 53-
6.7, Becton Dickinson Biosciences), Foxp3-APC (Clone, FJK-16s, eBioscience),
MHCI-FITC (Clone 28-1 4-8, eBioscience), L/D-eFluor 780 (eBioscience), L/D-
eFluor506 (eBioscience), and Fc receptor blocking antibody CD16/CD32 (clone
2.4G2, BD Biosciences). Prior to measuring, counting beads (Life Technologies)
were added to the cells. Measurements were performed on a BD LSR II or
FACSCanto II cytometer (BD Biosciences), and data were analyzed using FlowJo
software (Tree Star). Kupffer cell suspensions were stained using CD45-BV510, F4/
80-Biotin, CD26-AF488 (BD Bioscience), Fixable Live/Dead dye eFluor 780
(eBioscience), Streptavidin-BV605 (Biolegend), Clec4F (R&D systems), and anti-
goat-AF647 (Invitrogen) for 45 min at 4 °C in the dark in a two-step staining as
previously described61. Cells were FACS-puriﬁed with an Aria II and an Aria III
(BD Bioscience) and analyzed with FlowJo software (Tree Star). Kupffer cells were
gated as single live CD45+F4/80+Clec4F+ cells, and sorted to >73% purity (of total
single cells in post-sort cell suspension).
BMDM differentation and stimulation. BMDMs were obtained from bone
marrow cells ﬂushed from mouse femurs and tibia with ice-cold sterile RPMI 1640
medium supplemented with 40 ng/ml recombinant mouse M-CSF, 10% FCS, 1%
penicillin/streptadivin, glutamine, sodium pyruvate, and NEAA. Fresh M-CSF was
added on day 3 and medium was refreshed on day 5. On day 7, cells were seeded
and were either left untreated or treated with 5 µg/ml ultrapure LPS the next day
(E. coli 0111:B4 strain, Invivogen) for 1 h for assessment of A20 expression.
Peritoneal macrophage isolation. Mice were intraperitoneally injected with 3 ml
of 3% thioglycollate medium. Four days after injection, peritoneal cells were col-
lected. Mice were anesthetized using CO2 and injected with 5 ml PBS containing
5 mM EDTA in the peritoneal cavity. Cells were isolated from the peritoneum and
centrifuged at 300×g for 3 min after which the pellet was resuspended in 1 ml of
RPMI medium supplemented with 10% FCS, 1% penicillin/streptadivin, glutamine,
sodium pyruvat, and NEAA. Cells were seeded and left overnight at 37 °C with 5%
CO2. Peritoneal macrophages were used the day after and either left untreated or
treated with 5 µg/ml ultrapure LPS for 1 h for assessment of A20 expression.
Bioplex and IL-1β ELISA. Cytokine levels in culture medium and CSF were
determined by magnetic bead-based multiplex assay using Luminex technology
(Bio-Rad) and IL-1β ELISA (Affymetrix eBioscience), according to the manu-
facturers’ instructions.
Human patient samples. Tissue and CSF specimen were obtained from the
Human Brain and Spinal Fluid Resource Center (VA West Los Angeles Healthcare
Center, Los Angeles), sponsored by the NINDS/NIMH, National Multiple Sclerosis
Society, and Department of Veterans Affairs.
Statistical analysis. Results are expressed as mean ± SEM, excluding data from
in vitro pooled microglia that are expressed as mean ± SD. Statistical analysis
between two groups was assessed using a nonparametric Mann–Whitney U-
statistical test. mRNA expression levels of RNA-seq data were analyzed using an
unpaired t-test. Statistical analysis between multiple groups was assessed using
either one- or two-way ANOVA with Tukey correction for multiple comparison.
Relative body weight, clinical EAE scores, rectal body temperatures, and cell
death assay were analyzed as repeated measurements using the residual max-
imum likelihood approach as implemented in Genstat v1862. Brieﬂy, a linear
mixed model with genotype, time, and genotype × time interaction as ﬁxed terms,
replicate as random term, and subject.time used as residual term, was ﬁtted to
data. Times of measurement were set at equal intervals and an autoregressive
correlation structure of order 1 with unequal variances (i.e., heterogeneity across
time) was selected as best model ﬁt in all cases, based on the Aikake information
coefﬁcient. Signiﬁcances of the ﬁxed terms and signiﬁcances of the changes in
differences between genotype effects over time were assessed by an F-test.
Data availability. All RNA-seq datasets are accessible under GEO accession
number GSE107733.
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